GlaxoSmithKline Consumer Healthcare Pakistan Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was PKR 19,846.106 million compared to PKR 16,316.744 million a year ago. Operating income was PKR 1,832.300 million compared to PKR 1,892.143 million a year ago. Net income was PKR 1,262.008 million compared to PKR 1,257.518 million a year ago. Basic earnings per share from continuing operations was PKR 10.78 compared to PKR 10.74 a year ago.